February 2005
Journal of the American Dental Association (JADA);Feb2005, Vol. 136 Issue 2, p148
Academic Journal
Reports on research published in the December 15, 2004, issue of the journal “Clinical Cancer Research” indicating that RNA in saliva can be used to detect head and neck cancer. Number of clinically distinct types of RNA that people have in their saliva; Capability of a combination of four RNA biomarkers to provide a detectable signature for head and neck cancer.


Related Articles

  • Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer. Shiina, Marisa; Bourguignon, Lilly Y. W. // International Journal of Cell Biology;9/10/2015, Vol. 2015, p1 

    We determined that human head and neck cancer cells (HSC-3 cell line) contain a subpopulation displaying cancer stem cell (CSC) properties and are very tumorigenic. Specifically, we investigated whether different sizes of hyaluronan (HA) (e.g., 5 kDa, 20 kDa, 200 kDa, or...

  • A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Salazar, Carolina; Nagadia, Rahul; Pandit, Pratibala; Cooper-White, Justin; Banerjee, Nilanjana; Dimitrova, Nevenka; Coman, William; Punyadeera, Chamindie // Cellular Oncology (2211-3428);Oct2014, Vol. 37 Issue 5, p331 

    Background: MicroRNAs (miRNAs) are known to play an important role in cancer development by post-transcriptionally affecting the expression of critical genes. The aims of this study were two-fold: (i) to develop a robust method to isolate miRNAs from small volumes of saliva and (ii) to develop a...

  • Assessment of microsatellite instability in head and neck cancer using consensus markers. Yalniz, Zubeyde; Demokan, Semra; Suoglu, Yusufhan; Ulusan, Murat; Dalay, Nejat // Molecular Biology Reports;Oct2010, Vol. 37 Issue 7, p3541 

    Head and neck cancer is the sixth most common cancer in the world and one of the most lethal cancers. Microsatellite instability is an important characteristic of tumor cells and is observed both in presence and absence of mismatch repair gene mutations. The importance of microsatellite...

  • Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer. Reddy, Ram Bhupal; Bhat, Anupama Rajan; James, Bonney Lee; Govindan, Sindhu Valiyaveedan; Mathew, Rohit; DR, Ravindra; Hedne, Naveen; Illiayaraja, Jeyaram; Kekatpure, Vikram; Khora, Samanta S.; Hicks, Wesley; Tata, Pramila; Kuriakose, Moni A.; Suresh, Amritha // PLoS ONE;1/25/2016, Vol. 11 Issue 1, p1 

    The head and neck squamous cell carcinoma (HNSCC) transcriptome has been profiled extensively, nevertheless, identifying biomarkers that are clinically relevant and thereby with translational benefit, has been a major challenge. The objective of this study was to use a meta-analysis based...

  • Biomarkers of head and neck cancer, tools or a gordian knot? Lampri, Evangeli S.; Chondrogiannis, Georgios; Ioachim, Elli; Varouktsi, Anna; Mitselou, Antigoni; Galani, Aggeliki; Briassoulis, Evangelos; Kanavaros, Panagiotis; Galani, Vasiliki // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 7, p10340 

    Head and neck tumors comprise a wide spectrum of heterogeneous neoplasms for which biomarkers are needed to aid in earlier diagnosis, risk assessment and therapy response. Personalized medicine based on predictive markers linked to drug response, it is hoped, will lead to improvements in...

  • Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma. Plieskatt, Jordan L.; Rinaldi, Gabriel; Yanjung Feng; Levine, Paul; Easley, Samantha; Martinez, Elizabeth; Hashmi, Salman; Sadeghi, Nader; Brindley, Paul J.; Bethony, Jeffrey M.; Mulvenna, Jason P. // Journal of Translational Medicine;2014, Vol. 12 Issue 1, p3 

    Background Nasopharyngeal carcinoma (NPC) is a solid tumor of the head and neck. Multimodal therapy is highly effective when NPC is detected early. However, due to the location of the tumor and the absence of clinical signs, early detection is difficult, making a biomarker for the early...

  • Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients. Summerer, I; Unger, K; Braselmann, H; Schuettrumpf, L; Maihoefer, C; Baumeister, P; Kirchner, T; Niyazi, M; Sage, E; Specht, H M; Multhoff, G; Moertl, S; Belka, C; Zitzelsberger, H // British Journal of Cancer;6/30/2015, Vol. 113 Issue 1, p76 

    Background:The prediction of therapy response in head and neck squamous cell cancer (HNSCC) requires biomarkers, which are also a prerequisite for personalised therapy concepts. The current study aimed to identify therapy-responsive microRNAs (miRNAs) in the circulation that can serve as...

  • Special Symposium: Emerging concepts in head and neck cancer diagnostics and therapy.  // Annals of Oncology;Oct2010 Supplement 8, Vol. 21 Issue suppl_8, pviii31 

    No abstract available.

  • Development of a standardized flow cytometric method to conduct longitudinal analyses of intracellular CD3ζ expression in patients with head and neck cancer. UPRETI, DEEPAK; PATHAK, ALOK; KUNG, SAM K. P. // Oncology Letters;Mar2016, Vol. 11 Issue 3, p2199 

    Head and neck squamous cell carcinoma (HNSCC) is the sixth most common neoplasm in the world. The follow-up protocols currently available do not appear to diagnose treatment failures and recurrences early enough to provide the best treatment to improve the survival rates of patients. The...


Read the Article


Sign out of this library

Other Topics